Learn why this royalty company believes it is the best way to play commodities and inflation. on 06/22/2021. Learn More

The Latest Psychedelics Articles from Streetwise Reports

Promising Psychedelic Drug Trials Show Potential for a New Biotech Boom

Contributed Research
McAlinden Research Partners notes that continued advances in psychedelic therapies show potential to drive an investment boom that could reshape the future of medicine and mental health therapies. read more >
News Update

Firm Doubles in Size by Adding Four New Psychedelic Mental Health Clinics

News Update
Novamind Inc. is opening four new psychedelic mental health clinics as part of the company's national expansion strategy, giving it the capability to conduct 65,000 client visits in 2021. read more >

Merck Selects Rapidly Growing Psychedelic Medicine Company as Key Research Site

Novamind runs clinics, research sites and therapeutic retreats and is positioning itself for expansion. read more >

As Psychedelics Move Mainstream, Small Cap Positions Itself at the Center of the Industry

Two year old DELIC Corp. has gotten in on the ground floor of the nascent psychedelic sector. read more >
Showing Results: 1 to 4 of 4

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"NRG has big upside potential from here."
– Clive Maund, CliveMaund.com
"The oxide gold blanket promises to add a new chapter to CBR's MG."
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"I've found a good way to leverage the roaring copper trend in GCX."
– Brien Lundin, Gold Newsletter (Jefferson Financial)